Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 5 Formyltetrahydrofolate
2. 5 Formyltetrahydropteroylglutamate
3. 5-formyltetrahydrofolate
4. 5-formyltetrahydropteroylglutamate
5. Acid, Folinic
6. Calcium Folinate
7. Citrovorum Factor
8. Factor, Citrovorum
9. Folinate, Calcium
10. Folinic Acid
11. Folinic Acid Sf
12. Folinic Acid-sf
13. Leucovorin
14. Leucovorin, (d)-isomer
15. Leucovorin, (dl)-isomer
16. Leucovorin, (r)-isomer
17. Leucovorin, Calcium
18. Leucovorin, Calcium (1:1) Salt
19. Leucovorin, Calcium (1:1) Salt, (dl)-isomer
20. Leucovorin, Calcium (1:1) Salt, Pentahydrate
21. Leucovorin, Monosodium Salt
22. Leukovorin
23. Leukovorum
24. Monosodium Salt Leucovorin
25. N(5)-formyltetrahydrofolate
26. Wellcovorin
1. Calcium Folinate
2. Calcium Citrovorum Factor
3. Folinic Acid Calcium Salt
4. Folinic Acid-sf, Calcium Salt
5. (+)-l-folinic Acid, Calcium Salt
6. 1492-18-8
7. Nsc3590
8. Sr-05000001662
9. Pharmakon1600-01500364
10. Nsc757083
11. Nsc-757083
12. Sr-05000001662-1
13. Sr-05000001662-2
14. Glutamic Acid,6,7,8-tetrahydro-4-hydroxy-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), L-
15. L-glutamic Acid,4,5,6,7,8-hexahydro-4-oxo-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), (s)-
| Molecular Weight | 513.5 g/mol |
|---|---|
| Molecular Formula | C20H23CaN7O7+2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 513.1284869 g/mol |
| Monoisotopic Mass | 513.1284869 g/mol |
| Topological Polar Surface Area | 216 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 2 |
| Complexity | 911 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AF - Detoxifying agents for antineoplastic treatment
V03AF03 - Calcium folinate
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
16 Apr 2026
Reply
04 Oct 2025
Reply
13 Sep 2025
Reply
03 May 2025
Reply
11 Feb 2025
Reply
31 Jan 2025
Reply
23 Jan 2025
Reply
09 Sep 2024
Reply
03 Sep 2024
Reply
26 Jan 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Calcium Folinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcium Folinate manufacturer or Calcium Folinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Folinate manufacturer or Calcium Folinate supplier.
A Calcium Leucovorin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Leucovorin, including repackagers and relabelers. The FDA regulates Calcium Leucovorin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Leucovorin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Leucovorin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Calcium Leucovorin supplier is an individual or a company that provides Calcium Leucovorin active pharmaceutical ingredient (API) or Calcium Leucovorin finished formulations upon request. The Calcium Leucovorin suppliers may include Calcium Leucovorin API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Leucovorin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Calcium Leucovorin DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcium Leucovorin active pharmaceutical ingredient (API) in detail. Different forms of Calcium Leucovorin DMFs exist exist since differing nations have different regulations, such as Calcium Leucovorin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcium Leucovorin DMF submitted to regulatory agencies in the US is known as a USDMF. Calcium Leucovorin USDMF includes data on Calcium Leucovorin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcium Leucovorin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcium Leucovorin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Calcium Leucovorin Drug Master File in Japan (Calcium Leucovorin JDMF) empowers Calcium Leucovorin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Calcium Leucovorin JDMF during the approval evaluation for pharmaceutical products. At the time of Calcium Leucovorin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Calcium Leucovorin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Calcium Leucovorin Drug Master File in Korea (Calcium Leucovorin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Calcium Leucovorin. The MFDS reviews the Calcium Leucovorin KDMF as part of the drug registration process and uses the information provided in the Calcium Leucovorin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Calcium Leucovorin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Calcium Leucovorin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Calcium Leucovorin suppliers with KDMF on PharmaCompass.
A Calcium Leucovorin CEP of the European Pharmacopoeia monograph is often referred to as a Calcium Leucovorin Certificate of Suitability (COS). The purpose of a Calcium Leucovorin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Calcium Leucovorin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Calcium Leucovorin to their clients by showing that a Calcium Leucovorin CEP has been issued for it. The manufacturer submits a Calcium Leucovorin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Calcium Leucovorin CEP holder for the record. Additionally, the data presented in the Calcium Leucovorin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Calcium Leucovorin DMF.
A Calcium Leucovorin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Calcium Leucovorin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Calcium Leucovorin suppliers with CEP (COS) on PharmaCompass.
A Calcium Leucovorin written confirmation (Calcium Leucovorin WC) is an official document issued by a regulatory agency to a Calcium Leucovorin manufacturer, verifying that the manufacturing facility of a Calcium Leucovorin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium Leucovorin APIs or Calcium Leucovorin finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium Leucovorin WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium Leucovorin suppliers with Written Confirmation (WC) on PharmaCompass.
Calcium Leucovorin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Leucovorin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcium Leucovorin GMP manufacturer or Calcium Leucovorin GMP API supplier for your needs.
A Calcium Leucovorin CoA (Certificate of Analysis) is a formal document that attests to Calcium Leucovorin's compliance with Calcium Leucovorin specifications and serves as a tool for batch-level quality control.
Calcium Leucovorin CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Leucovorin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Leucovorin may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Leucovorin EP), Calcium Leucovorin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Leucovorin USP).